window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'UA-29484371-30');
Sunday , November 18 2018
Home | Tag Archives: Richard McCallum M.D

Tag Archives: Richard McCallum M.D

TTUHSC El Paso Professor Named Laureate by American College of Physicians

Richard McCallum, M.D., professor and founding chair of the Department of Internal Medicine at Texas Tech University Health Sciences Center El Paso (TTUHSC El Paso), was recently named a 2017 Laureate by the Texas Chapter of the American College of Physicians (ACP).

The Laureate Award is given to Texas physicians “who have demonstrated by their example and conduct an abiding commitment to excellence in medical care, education or research, and in service to their community, their chapter and the American College of Physicians,” said George Crawford, M.D., the Texas Southern ACP governor.

Dr. McCallum, who has been a member of different state chapters of the ACP since 1975, has made major advances in the diagnosis and treatment of the digestive disorder gastroparesis. In patients with gastroparesis, food moves through the stomach much slower than normal.

Dr. McCallum has researched the interactions between the brain and stomach to understand the causes of associated nausea and vomiting, and more effectively treat the disease.

Dr. McCallum holds three patents and is the inventor of a gastric pacemaker to help patients who cannot digest food properly. His findings have appeared in more than 450 peer-reviewed scientific articles and 120 textbook chapters. He has also edited 14 scientific textbooks on gastroenterology.

“As a leader in the Texas medical community; teacher of students, residents and gastroenterology fellows; prodigious investigator; nationally and internationally recognized contributor to the field of gastroenterology; clinician; researcher and chair of departments and societies, Dr. McCallum exemplifies the best aspects of our profession and was unanimously selected by the Texas ACP nomination committee for the Laureate Award,” Dr. Crawford said.

In his acceptance speech, Dr. McCallum noted that he was the second TTUHSC El Paso faculty member to receive the Laureate Award from the ACP, which has been awarded annually since 1985. Harry Davis II, M.D., associate professor and vice chair for education in the Department of Internal Medicine, received the award in 2011.

“The list of prior recipients of this honor includes some of the most well-known and productive physicians from the state of Texas,” Dr. Davis said. “I was deeply honored to be included among those who had received this lifetime pinnacle award.”

Dr. McCallum said he was proud of TTUHSC El Paso’s evolution since his arrival in 2009. He said he has had great mentors in his career, and is dedicated to mentoring medical students, residents, fellows and junior faculty.

“This award is indeed an honor for my career, as well as for the school,” Dr. McCallum said. “It is a recognition of my body of work focused on diagnosing and treating patients, while at the same time incorporating a teaching environment and a research culture to help produce the future leaders in clinical and academic gastroenterology.”

Dr. McCallum joined TTUHSC El Paso in 2009 as professor and founding chair of the Department of Internal Medicine. In 2014, he established the RotaCare Clinic in El Paso in partnership with the Rotary Club. This clinic is a resource for individuals with no other access to health care services, and provides first- and second-year medical students with one of their initial clinical experiences, under the supervision of licensed physicians.

In addition to his appointment at TTUHSC El Paso, Dr. McCallum is the director of gastroenterology research and the Center for Neurogastroenterology and GI Motility, and an honorary professor in the Departments of Medicine and Behavioral Sciences at the University of Queensland Australia. He has also served on the gastroenterology faculty at the Yale University School of Medicine, and as chief of gastroenterology and the GI fellowship program at the University of Virginia and the University of Kansas Medical Center.

TTUHSC El Paso Physician Hosts Online Q&A on Digestive Disorders

An upcoming Facebook Live Q&A will invite the community to listen in and pose health questions to a physician from Texas Tech University Health Sciences Center El Paso (TTUHSC El Paso).

In honor of Irritable Bowel Syndrome (IBS) Awareness Month, Richard McCallum, M.D., a physician and researcher in the Department of Internal Medicine, will host the session. Dr. McCallum, who specializes in gastroenterology, or stomach ailments, will take questions from viewers about a variety of gastrointestinal topics, including IBS, acid reflux, gluten intolerance and dietary needs for those with a sensitive stomach.

Dr. McCallum received his Doctor of Medicine from The University of Queensland in Brisbane, Australia and completed his residency at Washington University’s Barnes-Jewish Hospital in St. Louis, Missouri. He went on to serve as director of gastroenterology at the Yale University School of Medicine and later, was recruited by the University of Virginia and the University of Kansas Medical Center.

Dr. McCallum joined TTUHSC El Paso in 2010.

Participants are encouraged to submit their questions to Dr. McCallum in advance and RSVP on TTUHSC El Paso’s Facebook Live Q&A on Tummy Aches and Ailments event page.

This Q&A session is part of a new TTUHSC El Paso initiative called The Exam Room. The Exam Room encourages the El Paso community to engage with expert health care professionals at TTUHSC El Paso. Each month, The Exam Room will hold one or more public Q&As, each focusing on a different health-related topic and highlighting a TTUHSC El Paso health care specialist who has volunteered to answer questions on the subject.

What: Live health care Q&A open to the El Paso community

When: 11 a.m. Friday, April 14

Where: Online at facebook.com/ttuhscep

The Exam Room – April

$1.8 Million Grant Funds Digestive Disease Research in El Paso

Co-principal investigators Richard McCallum, M.D., and Irene Sarosiek, M.D., have received a five-year, $1.8 million grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The funds will support basic research and clinical trials on patients living with a digestive disorder named gastroparesis.

“Gastroparesis is prevalent here in El Paso; about 100,000 people in our region are affected by it,” says Dr. McCallum, a professor at Texas Tech University Health Sciences Center El Paso (TTUHSC El Paso). “This grant will help us collect new and important data on how the disorder affects Hispanics and others, but it will also help us provide health care to more patients.”

Gastroparesis is a disorder in which food moves through the stomach much slower than normal. The condition affects more than 10 million Americans and symptoms include chronic nausea, vomiting and abdominal pain. In severe cases, a permanent feeding tube is required to ensure adequate nutrition; a medical implant to stimulate the digestive system can also be provided for patients with profoundly severe, drug-resistant symptoms.

With the funding, the TTUHSC El Paso team will enroll patients to help test a new drug that may reduce the severity and frequency of their gastrointestinal problems. They’ll also examine the effectiveness of a novel diagnostic procedure for the condition. The technique was invented by the TTUHSC El Paso team, and if successful, could replace an invasive surgical procedure that’s currently used in patients with gastroparesis.

Individuals with gastroparesis who opt to participate in the TTUHSC El Paso studies will receive free health care related to the disorder, such as access to diagnostic tests like endoscopies and the latest treatment options.

“Many El Paso patients appreciate the opportunity to participate in our NIH-funded research,” Dr. Sarosiek says. “It gives them access to cutting-edge health care that they otherwise would not receive, and at the same time, it helps us find possible risk factors that could play a role in initiating the progression of gastroparesis in affected patients.”

Drs. McCallum and Sarosiek are studying the disease as part of their membership in the Gastroparesis Clinical Research Consortium (GpCRC), a prestigious national partnership that focuses on the cause of gastroparesis and therapies for the disorder. Membership includes Baylor College of Medicine, Johns Hopkins University and the Mayo Clinic, as well as TTUHSC El Paso.